NCT04051463View on ClinicalTrials.gov

Rhopressa for Corneal Edema Associated With Fuchs Dystrophy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Fuchs Endothelial Dystrophy
Interventions
DRUG

Netarsudil Ophthalmic Solution

Netarsudil eye drops instilled once daily

DRUG

Placebo

Placebo eye drops instilled once daily

Trial Locations (1)

46260

Price Vision Group, Indianapolis

All Listed Sponsors
lead

Price Vision Group

INDUSTRY

NCT04051463 - Rhopressa for Corneal Edema Associated With Fuchs Dystrophy | Biotech Hunter | Biotech Hunter